1. Market Research
  2. > MaxCyte, Inc. (MXCT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

MaxCyte, Inc. (MaxCyte) is a biotherapeutic company that conducts research and develops cell transfection technologies. The company utilizes flow electroporation technology for discovery, development and manufacturing of cell-based therapeutics for chronic and acute diseases. It offers MaxCyte STX, MaxCyte VLX and MaxCyte GT instruments. MaxCyte offers services which include transfection insourcing services, processing assemblies and quality systems. The company’s drug delivery application comprise GPCR’s, Ion channels, primary cell transfusion and maxcyte STX instrument. It markets its products through a network of distributors in the US, Japan, Taiwan and China. MaxCyte is headquartered in Gaithersburg, Maryland, the US.

MaxCyte, Inc. (MXCT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

MaxCyte, Inc. (MXCT) - Pharmaceuticals and Healthcare - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 5
MaxCyte, Inc., Pharmaceuticals and Healthcare Deals By Type, 2010 to YTD 2016 6
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2010 to YTD 2016 7
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals Summary, 2010 to YTD 2016 9
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deal Details 10
Partnerships 10
MaxCyte Partners with US Army Medical Research Institute Of Infectious Diseases 10
MaxCyte Enters into Research Agreement with Johns Hopkins University 11
Licensing Agreements 12
MaxCyte Expands Licensing Agreement With Medinet 12
Asset Transactions 14
Paragon Bioservices Acquires MaxCyte VLX Large Scale Transfection System And MaxCyte STX Scalable Transfection System From MaxCyte 14
CCS Cell Culture Service Acquires MaxCyte STX From MaxCyte 16
MaxCyte, Inc. - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
MaxCyte, Inc., Pharmaceuticals and Healthcare, Key Facts, 2015 1
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 5
MaxCyte, Inc., Pharmaceuticals and Healthcare Deals By Type, 2010 to YTD 2016 6
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2010 to YTD 2016 7
MaxCyte, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals Summary, 2010 to YTD 2016 9
MaxCyte Partners with US Army Medical Research Institute Of Infectious Diseases 10
MaxCyte Enters into Research Agreement with Johns Hopkins University 11
MaxCyte Expands Licensing Agreement With Medinet 12
Paragon Bioservices Acquires MaxCyte VLX Large Scale Transfection System And MaxCyte STX Scalable Transfection System From MaxCyte 14
CCS Cell Culture Service Acquires MaxCyte STX From MaxCyte 16
MaxCyte, Inc., Key Competitors 17
MaxCyte, Inc., Key Employees 18

List of Figures
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 1
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 1
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2010 to YTD 2016 1
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 5
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 6
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2010 to YTD 2016 7
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.